Food, Drugs, Healthcare, Life Sciences

Samsung Bioepis launches OPUVIZ aflibercept biosimilar in Europe, Amneal and Kashiv challenge Novartis omalizumab patent, EMA recommends two ranibizumab biosimilars, Eli Lilly acquires three vaccine companies...

A coalition of organ procurement organizations challenges a controversial CMS performance framework in federal court, but first must overcome a critical jurisdictional hurdle that could determine whether they can seek relief before facing potential decertification.

The U.S. Department of Health and Human Services has launched a new initiative using artificial intelligence to analyze years of audit reports from federal healthcare funding recipients across all 50 states. This program, called AERO, aims to identify unaddressed audit deficiencies and combat healthcare fraud by leveraging AI tools like ChatGPT to review extensive audit documentation that would typically go unexamined.